Cargando…

Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature

INTRODUCTION: Necrotizing fasciitis (NF) is an inflammatory disease of the soft tissue, which causes local tissue destruction and can lead to lethal septic shock. The therapy consists of early surgical treatment of the septic focus and an accompanying broad spectrum antibiotic therapy. Recent litera...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, C., Hecker, A., Grau, V., Padberg, W., Wolff, M., Henrich, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539184/
https://www.ncbi.nlm.nih.gov/pubmed/26288730
http://dx.doi.org/10.1016/j.amsu.2015.07.017
_version_ 1782386078434459648
author Koch, C.
Hecker, A.
Grau, V.
Padberg, W.
Wolff, M.
Henrich, M.
author_facet Koch, C.
Hecker, A.
Grau, V.
Padberg, W.
Wolff, M.
Henrich, M.
author_sort Koch, C.
collection PubMed
description INTRODUCTION: Necrotizing fasciitis (NF) is an inflammatory disease of the soft tissue, which causes local tissue destruction and can lead to lethal septic shock. The therapy consists of early surgical treatment of the septic focus and an accompanying broad spectrum antibiotic therapy. Recent literature considers the additional use of immunoglobulin therapy in severe soft skin and tissue infections. PRESENTATION OF CASE: In this report, we describe the case of a 33-year-old male patient treated at a university hospital intensive care unit because of an NF of his left leg. The patient rapidly developed a complicated septic disease after a minor superficial trauma. Despite intense microbiological diagnosis, no causative pathogens were identified. After non-responding to established broad anti-infective treatment, the patient received intravenous immunoglobulin, that rapidly improved his clinical condition. DISCUSSION: NF represents a disease processes, which is characterized by fulminant, widespread necrosis of soft tissue, systemic toxicity, and high mortality (>30%). Beside the surgical debridement and broad spectrum antibiotic therapy IVIg therapy might be an additional option in the treatment of NF. But the current literature supporting the use of IVIG in NF is largely based on retrospective or case-controlled studies, and only small randomized trials. CONCLUSION: The demonstrated case suggests that IVIg treatment of patients with NF can be considered in case of hemodynamic unstable, critically ill patients. Although randomized controlled trials are missing, some patients might benefit from diminishing hyperinflammation by immunoglobins.
format Online
Article
Text
id pubmed-4539184
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-45391842015-08-18 Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature Koch, C. Hecker, A. Grau, V. Padberg, W. Wolff, M. Henrich, M. Ann Med Surg (Lond) Case Report INTRODUCTION: Necrotizing fasciitis (NF) is an inflammatory disease of the soft tissue, which causes local tissue destruction and can lead to lethal septic shock. The therapy consists of early surgical treatment of the septic focus and an accompanying broad spectrum antibiotic therapy. Recent literature considers the additional use of immunoglobulin therapy in severe soft skin and tissue infections. PRESENTATION OF CASE: In this report, we describe the case of a 33-year-old male patient treated at a university hospital intensive care unit because of an NF of his left leg. The patient rapidly developed a complicated septic disease after a minor superficial trauma. Despite intense microbiological diagnosis, no causative pathogens were identified. After non-responding to established broad anti-infective treatment, the patient received intravenous immunoglobulin, that rapidly improved his clinical condition. DISCUSSION: NF represents a disease processes, which is characterized by fulminant, widespread necrosis of soft tissue, systemic toxicity, and high mortality (>30%). Beside the surgical debridement and broad spectrum antibiotic therapy IVIg therapy might be an additional option in the treatment of NF. But the current literature supporting the use of IVIG in NF is largely based on retrospective or case-controlled studies, and only small randomized trials. CONCLUSION: The demonstrated case suggests that IVIg treatment of patients with NF can be considered in case of hemodynamic unstable, critically ill patients. Although randomized controlled trials are missing, some patients might benefit from diminishing hyperinflammation by immunoglobins. Elsevier 2015-08-01 /pmc/articles/PMC4539184/ /pubmed/26288730 http://dx.doi.org/10.1016/j.amsu.2015.07.017 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Koch, C.
Hecker, A.
Grau, V.
Padberg, W.
Wolff, M.
Henrich, M.
Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature
title Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature
title_full Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature
title_fullStr Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature
title_full_unstemmed Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature
title_short Intravenous immunoglobulin in necrotizing fasciitis – A case report and review of recent literature
title_sort intravenous immunoglobulin in necrotizing fasciitis – a case report and review of recent literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539184/
https://www.ncbi.nlm.nih.gov/pubmed/26288730
http://dx.doi.org/10.1016/j.amsu.2015.07.017
work_keys_str_mv AT kochc intravenousimmunoglobulininnecrotizingfasciitisacasereportandreviewofrecentliterature
AT heckera intravenousimmunoglobulininnecrotizingfasciitisacasereportandreviewofrecentliterature
AT grauv intravenousimmunoglobulininnecrotizingfasciitisacasereportandreviewofrecentliterature
AT padbergw intravenousimmunoglobulininnecrotizingfasciitisacasereportandreviewofrecentliterature
AT wolffm intravenousimmunoglobulininnecrotizingfasciitisacasereportandreviewofrecentliterature
AT henrichm intravenousimmunoglobulininnecrotizingfasciitisacasereportandreviewofrecentliterature